NTRB Earnings Date: Dec 7, 2026 (Estimated) — Nutriband Inc.
NASDAQ
Updated
When is NTRB's next earnings date?
Nutriband Inc. (NTRB) is expected to report Q3 2026 earnings on Monday, December 7, 2026 at 6:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is revenue of $465,000.
How did NTRB do in its last earnings report?
In its most recent report on Sep 4, 2026 (Q2 2026), Nutriband Inc. posted EPS of -$0.07. Revenue was $437,514 against a $437,514 estimate. The stock's 1-day post-earnings move was +2.2%.
How much does NTRB stock move after earnings?
NTRB beat EPS estimates in 1 of its last 3 reported quarters. Over the last 8 reports the stock moved an average of 6.5% (up or down) in the day after earnings.
About Nutriband Inc.
Nutriband Inc. specializes in developing a diverse range of pharmaceutical products delivered via transdermal patches. The company's most advanced program centers on AVERSA fentanyl, an innovative fentanyl transdermal system engineered to prevent abuse. This extended-release patch provides healthcare professionals and patients with a continuous opioid therapy solution for the ongoing management of chronic pain. Its development pipeline also includes other treatments, such as AVERSA buprenorphine and AVERSA methylphenidate. Additionally, Nutriband is working on exenatide for individuals with type 2 diabetes and follicle stimulating hormone as a treatment for infertility. The company also holds a licensing agreement with Rambam Med-Tech Ltd. to further the development of RAMBAM Closed System Transfer Devices. Nutriband Inc. was founded in 2016 and its main offices are located in Orlando, Florida.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-04 | Q2 2026 | — | -0.07 | — | $437,514 | ➖ Inline | +2.18% | +16.00% | +11.89% |
| 2026-06-11 | Q1 2026 | — | -0.10 | — | $433,399 | — | -3.69% | -17.61% | -15.34% |
| 2025-12-11 | Q3 2025 | -1.99 | -0.32 | +83.92% | $346,058 | ✅ Beat | +1.64% | -10.02% | -13.70% |
| 2025-09-09 | Q2 2025 | -0.17 | -0.18 | -5.88% | $622,452 | ❌ Miss | -1.32% | +17.60% | +39.80% |
| 2025-04-28 | Q4 2024 | — | -0.51 | — | $642,379 | — | +9.77% | +19.74% | +12.41% |
| 2024-12-04 | Q3 2024 | — | -0.12 | — | $645,796 | — | +5.07% | +13.77% | +22.46% |
| 2024-09-03 | Q2 2024 | — | -0.15 | — | $442,830 | — | +15.44% | +0.25% | +47.30% |
| 2024-05-31 | Q1 2024 | — | -0.21 | — | $408,532 | — | +13.03% | -4.59% | +8.07% |
Showing last 8 quarters.